Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Arthritis Research & Therapy|December 31, 2018
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticaseBrian F Mandell, Anthony E Yeo, Peter E Lipsky
Arthritis Research & Therapy|August 19, 2017
Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory goutLeonard H Calabrese, Arthur Kavanaugh, Anthony E Yeo, et al.
Arthritis Research & Therapy|July 1, 2020
Development of a multivariable improvement measure for goutNaomi Schlesinger, N Lawrence Edwards, Anthony E Yeo, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Improvement in hepatic fibrosis estimated by Fibrosis-4 index in pegloticase treated chronic refractory gout patientsNaomi Schlesinger, Vinod K Rustgi, Anthony E Yeo, et al.
The Journal of Rheumatology|June 17, 2019
Dissociation Between Clinical Benefit and Persistent Urate Lowering in Patients with Chronic Refractory Gout Treated with PegloticaseMichael H Pillinger, Theodore R Fields, Anthony E Yeo, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2019
Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic GoutRichard J Johnson, Hyon K Choi, Anthony E Yeo, et al.
Clinical and Experimental Rheumatology|July 27, 2023
Increased frequency of hepatic steatosis and fibrosis in patients with gout detected by transient elastographyNaomi Schlesinger, Ankoor Patel, Vinod K Rustgi, et al.
Rheumatology (Oxford, England)|March 8, 2019
Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticaseN Lawrence Edwards, Jasvinder A Singh, Orrin Troum, et al.
Pageof 2